We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Bioquell | LSE:BQE | London | Ordinary Share | GB0004992003 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 597.00 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMBQE
RNS Number : 9540H
Bioquell PLC
24 August 2016
Bioquell
24 August 2016
Bioquell PLC
Termination of Strategic Review
As a result of the termination of the Strategic Review, announced with the publication of the Company's interim results earlier today, the Company is no longer in an offer period for the purposes of the Takeover Code and, accordingly, the requirement to make disclosures under Rule 8 of the Code has now ceased.
In accordance with Rule 26.1 of the Code, a copy of this announcement will be published, subject to certain restrictions relating to persons in any restricted jurisdiction, at www.bioquell.com
Ends
For further information contact:
Bioquell PLC 01264 835900 Ian Johnson Chairman Michael Roller Finance Director
This information is provided by RNS
The company news service from the London Stock Exchange
END
FUREAKPDALPKEFF
(END) Dow Jones Newswires
August 24, 2016 02:05 ET (06:05 GMT)
1 Year Bioquell Chart |
1 Month Bioquell Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions